SoFi Technologies closes out June with a fresh internal signal cutting against the grain of a market that remains deeply skeptical: the CEO bought shares on the same day executives were selling.
On June 16, while several officers — including the CTO, an EVP, and the company secretary — were offloading stock at roughly $17.60, CEO Anthony Noto spent $251k buying 13,888 shares at $18.06. That's a modest absolute sum for a chief executive, but the direction matters. Noto now holds nearly 12 million shares, and this purchase added to his position rather than trimming it. Over the trailing 90 days, insiders are net buyers in aggregate — net shares of roughly 616,000 and net value of approximately $10.6 million — though the recent transaction log is dominated by sell volume from officers exercising awards. The CEO buy on a down day, against the grain of his own team's selling, is the standout detail.
The broader positioning picture remains hostile. Short interest has climbed 14% over the past month to 16% of the free float — 192 million shares as of June 30. Bears held their positions through a 3.7% weekly gain for the stock, which is the clearest evidence that this isn't a distressed short being squeezed out; it's a conviction bet being maintained. The borrow market offers no squeeze pressure as a counterweight: availability runs at 117%, well above the 80% level touched in early June, and cost to borrow has actually eased roughly 11% on the week to under 0.5% — among the cheapest financing in the lending pool. The ORTEX short score of 66 ranks in the bottom 7th percentile of the universe, flagging this as one of the more heavily shorted names on the platform.
Options traders are similarly cautious, and this signal has now been elevated for long enough to be structural rather than transient. The put/call ratio closed the week at 0.50, nearly three standard deviations above its 20-day average of 0.43 — a z-score of 2.92 that has held above 2.5 for the better part of a week. As the previous two notes flagged, this PCR spike first appeared around June 23 and has not reverted. The 52-week high on the PCR is 0.68, so there is overhead room for more defensive positioning. With Q2 earnings set for July 27, the memory of April's print — a 12.3% single-day drop followed by an additional 11% loss over the following week — is clearly feeding demand for downside protection.
The Street reflects a similar lack of conviction. Analyst targets were cut across the board after April earnings: Citigroup (Buy, $30), Needham (Buy, $25), and UBS (Neutral, $21) all reduced targets in the May 4–12 window, following earlier cuts from Goldman Sachs and TD Cowen. The consensus mean target sits at $20.90 against a current price of $17.93 — implying roughly 17% theoretical upside — but the direction of travel on targets has been consistently downward since the Q1 report. The bear case centres on credit risk embedded in the lending book and a valuation that bulls argue doesn't adequately price economic sensitivity. The P/E multiple has expanded about 1.2 turns over the past 30 days to roughly 24.8x, a modest re-rating that bulls can point to as early normalisation. Close peer UPST gained 12.6% on the week and DAVE added 17.2%, both outpacing SOFI's 3.7% — a reminder that the fintech trade has legs elsewhere even as SOFI carries its heavier short burden.
The Noto purchase is the data point most worth tracking into the July 27 earnings call: whether it represents informed confidence ahead of a better-than-feared Q2 print, or simply a routine signal that gets overwhelmed by the macro and credit dynamics that drove April's selloff, is the question the positioning on both sides is implicitly debating.
See the live data behind this article on ORTEX.
Open SOFI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
